title: Anti-tumor necrosis factor monoclonal antibody for steroid-dependent TB-IRIS in AIDS.
authors.affiliation: aUniversité Paris Descartes, Sorbonne Paris Cité, Service des Maladies Infectieuses et Tropicales et Centre d'Infectiologie Necker Pasteur, IHU Imagine bAPHP, Unité Fonctionnelle de Thérapeutique en Immuno-Infectiologie, CHU Hôtel Dieu cUniversité Paris Descartes, EA 7327 Faculté de Médecine Site Necker, Sorbonne Paris Cité, Paris dUniversité Paris Descartes, Sorbonne Paris Cité, Service de Radiologie adulte, CHU Necker-Enfants Malades eInstitut Pasteur, Unité de Mycologie Moléculaire, Centre National de Référence Mycoses Invasives et Antifongiques, Centre National de la Recherche Scientifique, Unité Recherche Associée, Paris, France. *Jade Ghosn and Karima Amazzough contributed equally to the writing of this article.
authors.forename: Clémence
authors.initials: C
authors.lastname: Richaud
authors.forename: Jade
authors.initials: J
authors.lastname: Ghosn
authors.forename: Karima
authors.initials: K
authors.lastname: Amazzough
authors.forename: Sylvain
authors.initials: S
authors.lastname: Poiree
authors.forename: Olivier
authors.initials: O
authors.lastname: Lortholary
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000188:drug therapy; D000328:Adult; D006801:Humans; D054019:Immune Reconstitution Inflammatory Syndrome / Q000188:drug therapy*; D007155:Immunologic Factors / Q000627:therapeutic use*; D000069285:Infliximab / Q000627:therapeutic use*; D008297:Male; D013256:Steroids / Q000627:therapeutic use*; D016896:Treatment Outcome; D014376:Tuberculosis / Q000150:complications* / Q000188:drug therapy; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D007155:Immunologic Factors; D013256:Steroids; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab